Literature DB >> 24065538

Association between the -1438G/A and T102C polymorphisms of 5-HT2A receptor gene and obstructive sleep apnea: a meta-analysis.

Ying Wu1, Hong-Bing Liu, Ming Ding, Jian-Nan Liu, Xuan-Feng Zhu, Jian-Hua Gu, Gan Lu.   

Abstract

The serotonin 2A (5-HT2A) receptor has been implicated in obstructive sleep apnea (OSA). Single nucleotide polymorphisms (SNPs) in the 5-HT2A gene have been found in OSA, the most common being -1438G/A and T102C; however, studies of the association between 5-HT2A SNPs and OSA risk have reported inconsistent findings. A meta-analysis was performed to quantitatively review the association between -1438G/A and T102C SNPs and OSA. Five studies, including 791 subjects for -1438G/A genotype and 1,068 subjects for T102C genotype, were selected. Pooled data analysis of the -1438G/A genotype indicated a significantly increased OSA risk was associated with two variant genotypes (AA vs. AG+GG: OR 3.023, 95 % CI 2.169-4.213, P = 0.506 for heterogeneity; A allele carriers vs. GG: OR 1.938, 95 % CI 0.879-4.274, P = 0.012 for heterogeneity). Stratification analysis by gender supported the association in males, but not females. For the T102C genotype, no significantly increased OSA risk was associated with the two variant genotypes (CC vs. CT+TT: OR 1.065, 95 % CI 0.787-1.442, P = 0.361 for heterogeneity; C allele carriers vs. TT: OR 0.979, 95 % CI 0.737-1.3, P = 0.9 for heterogeneity).In conclusions, meta-analysis indicated that the -1438G/A, and not T102C, polymorphism of 5-HT2A is a positive risk factor of OSA, especially in males.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24065538     DOI: 10.1007/s11033-013-2734-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  51 in total

1.  A candidate gene study of obstructive sleep apnea in European Americans and African Americans.

Authors:  Emma K Larkin; Sanjay R Patel; Robert J Goodloe; Yali Li; Xiaofeng Zhu; Courtney Gray-McGuire; Mark D Adams; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 3.  Multi-dimensional phenotyping: towards a new taxonomy for airway disease.

Authors:  A J Wardlaw; M Silverman; R Siva; I D Pavord; R Green
Journal:  Clin Exp Allergy       Date:  2005-10       Impact factor: 5.018

Review 4.  Expression genetics and the phenotype revolution.

Authors:  Robert W Williams
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

5.  Association of the -1438G/A polymorphism of the 5-HT2A receptor gene with obstructive sleep apnea syndrome.

Authors:  Yildirim A Bayazit; Metin Yilmaz; Tansu Ciftci; Emin Erdal; Oguz Kokturk; Tuba Gokdogan; Yusuf K Kemaloglu; Erdogan Inal
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2006-01-30       Impact factor: 1.538

6.  Association of sleep-disordered breathing and the occurrence of stroke.

Authors:  Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; T Douglas Bradley
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

7.  [Association study of sleep apnea syndrome and polymorphisms in the serotonin transporter gene].

Authors:  Wei-hua Yue; Po-zi Liu; Wei Hao; Xiang-hui Zhang; Xiao-ping Wang; Ji-shui Zhang; Xu-hui Zhou; Yong-biao Xie; Ming Ni
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2005-10

8.  The genetics of sleep apnea.

Authors:  Susan Redline; Peter V. Tishler
Journal:  Sleep Med Rev       Date:  2000-12       Impact factor: 11.609

9.  Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.

Authors:  B E H Sumner; K E Grant; R Rosie; Ch Hegele-Hartung; K-H Fritzemeier; G Fink
Journal:  Neurosci Lett       Date:  2007-02-15       Impact factor: 3.046

10.  Polymorphisms in the 5-HTR2A gene related to obstructive sleep apnea syndrome.

Authors:  Vânia Belintani Piatto; Thiago Bittencourt Ottoni de Carvalho; Nely Silva Aragão De Marchi; Fernando Drimel Molina; José Victor Maniglia
Journal:  Braz J Otorhinolaryngol       Date:  2011-06
View more
  7 in total

1.  5-HTR2A and IL-6 polymorphisms and obstructive sleep apnea-hypopnea syndrome.

Authors:  Wenjuan Wu; Zhijun Li; Tingyu Tang; Jinyan Wu; Fang Liu; Liang Gu
Journal:  Biomed Rep       Date:  2015-12-16

Review 2.  Mechanisms of sudden unexplained death in epilepsy.

Authors:  Alica M Goldman
Journal:  Curr Opin Neurol       Date:  2015-04       Impact factor: 5.710

3.  Obstructive sleep apnea syndrome susceptible genes in the Chinese population: a meta-analysis of 21 case-control studies.

Authors:  Fen Lan; Chao Cao; Jinkai Liu; Wen Li
Journal:  Sleep Breath       Date:  2015-04-28       Impact factor: 2.816

4.  Nutrigenetic genotyping study in relation to Sleep Apnea Clinical Score.

Authors:  K Gkouskou; I M Vlastos; D Chaniotis; A Markaki; K Choulakis; E Prokopakis
Journal:  Sleep Breath       Date:  2018-10-17       Impact factor: 2.816

5.  Relationship between Occupational Stress, 5-HT2A Receptor Polymorphisms and Mental Health in Petroleum Workers in the Xinjiang Arid Desert: A Cross-Sectional Study.

Authors:  Ting Jiang; Hua Ge; Jian Sun; Rong Li; Rui Han; Jiwen Liu
Journal:  Int J Environ Res Public Health       Date:  2017-04-10       Impact factor: 3.390

6.  Relationship between Job Stress and 5-HT2A Receptor Polymorphisms on Self-Reported Sleep Quality in Physicians in Urumqi (Xinjiang, China): A Cross-Sectional Study.

Authors:  Xiaoyan Gao; Hua Ge; Yu Jiang; Yulong Lian; Chen Zhang; Jiwen Liu
Journal:  Int J Environ Res Public Health       Date:  2018-05-21       Impact factor: 3.390

7.  A Cross-Sectional Study on the Relationship Among Cytokines, 5-HT2A Receptor Polymorphisms, and Sleep Quality of Non-manual Workers in Xinjiang, China.

Authors:  Juan Wang; Xiaoyan Gao; Pengcheng Gao; Jiwen Liu
Journal:  Front Psychiatry       Date:  2022-04-06       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.